Connect with us

Technology

SterlingBio Secures Global Distribution and Operation of SureClinical’s Validated Clinical Trial Applications, Platform, and Compliant Cloud

Published

on

SterlingBio Aims to Democratize Clinical Trial Application Affordability, Accessibility, and Availability to Reduce Drug Development Costs Globally

REDWOOD SHORES, Calif., May 31, 2024 /PRNewswire-PRWeb/ — SterlingBio, a leading US woman-owned Contract Research Organization (CRO), is thrilled to announce that it has secured exclusive global distribution rights for SureClinical’s cutting-edge eClinical apps, platform, and cloud, including the management of all existing SureClinical cloud operations and customer instances. This strategic transaction represents a significant step forward in the democratization of clinical trial data and solutions, reinforcing SterlingBio’s commitment to helping organizations, patients and agencies achieve better results in healthcare through innovative and accessible clinical research applications, services and clinical intelligence.

“Unlike a handful of Big CROs that control access and prices to clinical software and services, SterlingBio aims to provide a more affordable alternative. With SterlingBio, clients can receive Smart CRO services and their apps for free,” said Catherine Schmidt, CEO of SterlingBio.

In an unprecedented move to support current and future clients, SterlingBio will offer SureClinical applications for free with select SterlingBio managed application service agreements. This initiative underscores SterlingBio’s commitment to providing exceptional value and support to its clients, ensuring they have access to the best clinical tools and services at an affordable price.

“We are excited to secure the SureClinical eClinical ecosystem and cloud operations for our clients,” said Catherine Schmidt, CEO of SterlingBio. “Unlike a handful of Big CROs that control access and prices to clinical software and services, SterlingBio aims to provide a more affordable alternative. With SterlingBio, clients can receive Smart CRO services and their apps for free.”

SterlingBio’s Validated Clinical Apps and Cloud
SterlingBio’s SureClinical applications and platform will continue to be available to existing and new clients through the SureClinical Compliant Cloud, which maintains multiple FDA, EU, HIPAA, and ISO certifications, independently compliance validated by USDM. In order to assure a seamless transition for existing SureClinical client instances and subscriptions, SterlingBio will continue to provide support through the end of existing subscription agreements at no additional cost. Alternatively, existing customers can transition to a new Managed Application Services agreement under SterlingBio, with CRO services, support, administration, and management. Additional information on SterlingBio managed services is available at http://www.SterlingBio.com, along with an FAQ on the SureClinical / SterlingBio transition.

SureClinical applications and platform are renowned for advanced features that streamline and automate clinical trial processes, improve data quality, and enhance regulatory compliance. By offering the SureClinical eClinical ecosystem with SterlingBio’s existing Managed Application Services, SterlingBio aims to provide biopharma companies with an affordable, comprehensive solution that simplifies the complexities of clinical trial management, democratizing access to clinical solutions for almost any clinical researcher or sponsor regardless of size.

Initially released in 2014, SureClinical’s applications were built on a flexible framework that supports interoperability with virtually any web application. SureClinical’s apps and platform support multiple application standards, such as the OASIS eTMF standard. As an early proponent of AI and machine learning, SureClinical’s apps were built on web standards including RDF/XML, a technology used in AI knowledge graphs for automated data classification, search, and analysis. SureClinical applications have been used by thousands of users on hundreds of clinical trials globally. SureClinical applications and platform have been independently compliance validated by USDM for FDA, EU, ISO, GDPR, SOC, HIPAA, and other compliance standards and have passed multiple regulatory agency audits and inspections.

Further demonstrating its commitment and mission to democratize clinical applications accessibility, affordability, and availability, SterlingBio will be separately announcing its sponsorship for a community-driven open-source initiative to connect any eClinical app, data, or cloud for free use by anyone in clinical research and development.
For more information about SterlingBio’s new services and the benefits of SureClinical’s clinical software, please visit http://www.SterlingBio.com or contact SterlingBio PR at info@sterlingbio.com, or by phone at 1-650-206-2054.

About SterlingBio
SterlingBio, founded in 2001, is a woman-owned Contract Research Organization (CRO) based in the USA. SterlingBio, the ‘We Care CRO™,’ is dedicated to providing top-tier clinical research and development services to the biopharma industry. With a focus on managed application services, consulting, technical services and staffing, SterlingBio is committed to helping organizations, patients and agencies achieve better results in healthcare. 

For media inquiries, please contact: 
SterlingBio PR
info@SterlingBio.com
1-650-206-2054

Media Contact

SterlingBio PR, SterlingBio, 1-650-206-2054, info@sterlingbio.com, https://www.sterlingbio.com

View original content to download multimedia:https://www.prweb.com/releases/sterlingbio-secures-global-distribution-and-operation-of-sureclinicals-validated-clinical-trial-applications-platform-and-compliant-cloud-302161004.html

SOURCE SterlingBio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Bloomberg Introduces Spread-to-Benchmark Quoting for EUR and GBP Portfolio Trading Baskets

Published

on

By

LONDON, June 2, 2026 /PRNewswire/ — Bloomberg today announced the launch of Spread-to-Benchmark quoting and trading for Euro (EUR) and Sterling (GBP) denominated portfolio trades through its Portfolio Trading Basket Builder (PTBB). The new functionality expands the range of quoting protocols available for European credit portfolio trading and reflects growing client demand for spread-based execution workflows, alongside increased dealer support for the convention across EUR and GBP markets.

Spread-to-Benchmark quoting is a well-established protocol for USD credit portfolio trades and is used by market participants to evaluate and execute portfolio trades. By extending this workflow to EUR and GBP portfolio trades, Bloomberg enables clients and dealers to transact using a familiar spread-based methodology across additional credit markets. 

The introduction of Spread-to-Benchmark quoting for EUR and GBP baskets reflects increased client interest in evaluating portfolio trades through a spread-based lens and the growing adoption of spread-based execution workflows in European credit markets. The workflow provides market participants with an additional framework for assessing the relationship between credit spread risk and underlying government bond yields when pricing and executing portfolio trades. 

Additional Workflow Flexibility 
The workflow complements Bloomberg’s existing portfolio trading capabilities, which support the full range of market-standard quoting conventions, including Price, Yield, Spread-to-Benchmark and Spread based workflows that reference Bloomberg’s evaluated pricing service (BVAL). This gives clients flexibility to compare and execute portfolio trades using the quoting methodology that best aligns with their investment objectives, execution preferences and internal risk management processes. 

“European credit clients continue to look for execution workflows that reflect how they evaluate risk and monitor portfolio trading outcomes,” said Harry Street, Global Head of Credit and Equities Trading Product at Bloomberg. “By expanding dealer support for Spread-to-Benchmark quoting for EUR and GBP baskets, Bloomberg is broadening the range of workflow options available to clients trading European credit portfolios.” 

“Portfolio trading workflows in fixed income continue to become more sophisticated as institutional investors look for ways to evaluate execution quality in changing market conditions,” said Kevin McPartland, Head of Market Structure & Technology Research at Crisil Coalition Greenwich. “Spread-based quoting helps market participants more clearly distinguish between the impacts of credit spread and underlying rates movements when determining how best to execute a portfolio trade.” 

Bloomberg’s Electronic Markets solutions are used by leading financial institutions to trade efficiently in over 175 markets around the world. More than 9,000 client firms use Bloomberg Electronic Markets to access industry-leading depth and breadth of liquidity across asset classes from over 800 dealers globally. Bloomberg Electronic Markets provides market participants with comprehensive solutions across the trading lifecycle, including robust price transparency, analytics, automation and execution, powered by Bloomberg’s high-quality, multi-asset class data and tools.

About Bloomberg
Bloomberg is a global leader in business and financial information, delivering trusted data, news, and insights that bring transparency, efficiency, and fairness to markets. The company helps connect influential communities across the global financial ecosystem via reliable technology solutions that enable our customers to make more informed decisions and foster better collaboration. For more information, visit Bloomberg.com/company or request a demo.

View original content to download multimedia:https://www.prnewswire.com/news-releases/bloomberg-introduces-spread-to-benchmark-quoting-for-eur-and-gbp-portfolio-trading-baskets-302787922.html

SOURCE Bloomberg L.P.

Continue Reading

Technology

Dr. Sunho Kang, a senior battery-technology executive with leadership experience at major global battery and EV manufacturers, joins TeraWatt Technology as Head of Product and Technology

Published

on

By

SAN FRANCISCO, June 2, 2026 /PRNewswire/ — TeraWatt Technology Inc. (Headquartered in California, USA) is pleased to announce that Dr. Sunho Kang has joined the company as Head of Product and Technology.

Dr. Kang is a globally recognized battery-technology executive with more than 25 years of leadership experience spanning the United States, Asia, and Europe, and a distinguished track record of advancing innovations from laboratory research through gigafactory-scale production. He has held senior executive positions at world-leading organizations including Samsung SDI, Apple, and Volkswagen Group of America, and brings deep expertise in lithium-ion battery materials, cell engineering, and product industrialization across a broad range of applications, including electric vehicles and energy storage systems.

At TeraWatt, Dr. Kang will lead global product development and the commercialization of TeraWatt’s battery technology platform, aiming to accelerate the delivery of TeraWatt’s competitive products as well as the technology and commercialization roadmap including manufacturing scale-up.

Dr. Kang commented:

“I am thrilled to join TeraWatt Technology as Head of Product and Technology. TeraWatt’s innovative battery platform presents a tremendous opportunity to push the boundaries of lithium-ion technology, and I look forward to working with the team to accelerate product development and commercialization to deliver meaningful impact.”

TeraWatt Technology founder CEO Ken Ogata, Ph.D. commented:

“We are thrilled to welcome Dr. Kang as our Head of Product and Technology. His deep expertise in battery materials, cell engineering, and productization will be instrumental in accelerating TeraWatt’s product roadmap and technology leadership. Together with Dr. Kang, we will continue to drive our mission forward.”

About TeraWatt Technology Inc.
TeraWatt Technology Inc. is a California-based company that produces lightweight, high-power, and safe next-generation lithium-ion batteries.

Company Overview
Name: TeraWatt Technology Inc.
Representative: Co-founder and CEO Ken Ogata
Headquarters: 28 Geary St, Suite 650, San Francisco, CA 94108, United States
Founded: January 2020
Established: December 2019
URL: https://www.terawatt-technology.com/

 

View original content:https://www.prnewswire.com/news-releases/dr-sunho-kang-a-senior-battery-technology-executive-with-leadership-experience-at-major-global-battery-and-ev-manufacturers-joins-terawatt-technology-as-head-of-product-and-technology-302786854.html

SOURCE TeraWatt Technology Inc.

Continue Reading

Technology

Tencent Cloud and Soniox Announce Strategic Partnership: Combining Advanced Speech-to-Text (STT) Technology with Global Real-Time Infrastructure

Published

on

By

HONG KONG, June 2, 2026 /PRNewswire/ — Tencent Cloud, the cloud business of global technology company Tencent, today announced a strategic partnership with Soniox, a San Francisco-based speech AI company that specializes in developing high-accuracy, low-latency speech AI solutions. The collaboration integrates Soniox’s speech-to-text (STT) technology with Tencent Cloud’s Real-Time Communication (TRTC) enterprise-grade global infrastructure, enabling enterprises to build and deploy multilingual voice AI applications across 200+ countries and regions.

Elevating Enterprise Voice AI at a Global Scale

In enterprise voice AI deployments, latency directly affects user experience and application reliability. The integration of Soniox’s high-accuracy, low-latency STT with TRTC’s global transmission infrastructure reduces latency across the entire pipeline, creating a comprehensive end-to-end solution for enterprises deploying conversational AI applications worldwide.    

Soniox is the voice platform for every language. Unlike legacy speech AI, which was built primarily for English-speakers, Soniox delivers native-speaker accuracy across 60+ languages. Its technology can handle mid-sentence language switching — a user can switch between English and Chinese in a single utterance, and Soniox will capture every word with complete accuracy. All of this works through a single API that works for both speech-to-text and text-to-speech.

By integrating TRTC, the partnership leverages an enterprise-grade real-time communication backbone featuring more than 3,200 global nodes, sub-300 ms worldwide latency, and advanced capabilities such as AI noise suppression and weak-network resilience. These capabilities enable conversational AI applications to operate reliably across diverse network environments, including regions such as Southeast Asia and Africa.

With the roll out of this partnership, developers can integrate the Soniox STT API directly within the Tencent Cloud console. Whether targeting English-speaking markets or supporting languages such as Arabic, Hindi, and Malay, enterprises can build global voice applications — including intelligent customer service, voice assistants, real-time translation, and meeting transcription — to address the demands of expansion into emerging markets and multilingual scenarios.

Wison Xie, Head of Product at Tencent RTC, stated: “Tencent RTC has always been committed to providing reliable real-time communication infrastructure for global enterprises. Our partnership with Soniox brings together our strengths in enterprise-grade audio transmission and Soniox’s advanced speech recognition technology. Together, we are making it easier for businesses to deploy accurate, low-latency voice AI applications across any language and any market.”

Klemen Simonic, CEO at Soniox Inc., stated “At Soniox, our mission is to help businesses understand every word, in any language, with native speaker accuracy and exceptional speed. Partnering with Tencent Cloud combines our speech AI with world-class real-time infrastructure, enabling enterprises to build voice AI experiences that scale globally with low latency and reliability.”

About Tencent Cloud:

Tencent Cloud, one of the world’s leading cloud companies, is committed to creating innovative solutions to resolve real-world issues and enabling digital transformation for smart industries. Through our extensive global infrastructure, Tencent Cloud provides businesses across the globe with stable and secure industry-leading cloud products and services, leveraging technological advancements such as cloud computing, Big Data analytics, AI, IoT, and network security. It is our constant mission to meet the needs of industries across the board, including the fields of gaming, media and entertainment, finance, healthcare, property, retail, travel, and transportation.

About Tencent RTC:

Tencent RTC provides real-time communication solutions, including audio/video calling, live streaming, and in-game voice. With enterprise-grade security, AI-powered enhancements, and a global network of over 3,200 nodes, Tencent RTC powers mission-critical communication for customers worldwide.

About Soniox:

Soniox is a next-generation voice AI company bringing about the end of English-first speech AI. Most people on the planet did not grow up speaking English and often mix languages mid-sentence; and yet legacy speech AI was built for just English. Soniox is different: native-speaker accuracy across 60+ languages, true mid-sentence language switching, and flawless alphanumeric recognition that legacy providers still can’t match. For developers building global apps, Soniox is the only option. Try it for yourself at soniox.com.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/tencent-cloud-and-soniox-announce-strategic-partnership-combining-advanced-speech-to-text-stt-technology-with-global-real-time-infrastructure-302786832.html

SOURCE Tencent Cloud

Continue Reading

Trending